From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy
Combination type
MCF-7 cells
MCF-10A cells
CI
Interaction type
Free paclitaxel + free curcumin solution
0.23
Synergistic
0.53
Paclitaxel niosome + curcumin niosome
0.35